- Home
- MCB vs SIGA Comparison
MCB vs SIGA Comparison
Compare MCB & SIGA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MCB
- SIGA
- Stock Information
- Founded
- MCB 1999
- SIGA 1995
- Country
- MCB United States
- SIGA United States
- Employees
- MCB N/A
- SIGA N/A
- Industry
- MCB Major Banks
- SIGA Biotechnology: Pharmaceutical Preparations
- Sector
- MCB Finance
- SIGA Health Care
- Exchange
- MCB Nasdaq
- SIGA Nasdaq
- Market Cap
- MCB 626.0M
- SIGA 551.0M
- IPO Year
- MCB 2017
- SIGA 1997
- Fundamental
- Price
- MCB $64.52
- SIGA $5.94
- Analyst Decision
- MCB Buy
- SIGA
- Analyst Count
- MCB 4
- SIGA 0
- Target Price
- MCB $63.13
- SIGA N/A
- AVG Volume (30 Days)
- MCB 83.1K
- SIGA 518.3K
- Earning Date
- MCB 10-17-2024
- SIGA 11-07-2024
- Dividend Yield
- MCB N/A
- SIGA 10.10%
- EPS Growth
- MCB 8.87
- SIGA N/A
- EPS
- MCB 5.34
- SIGA 1.20
- Revenue
- MCB $258,166,000.00
- SIGA $173,731,386.00
- Revenue This Year
- MCB N/A
- SIGA $16.98
- Revenue Next Year
- MCB $7.14
- SIGA $16.49
- P/E Ratio
- MCB $12.08
- SIGA $4.97
- Revenue Growth
- MCB 3.52
- SIGA 399.31
- 52 Week Low
- MCB $32.46
- SIGA $4.26
- 52 Week High
- MCB $66.59
- SIGA $12.83
- Technical
- Relative Strength Index (RSI)
- MCB 66.04
- SIGA 30.77
- Support Level
- MCB $62.96
- SIGA $6.90
- Resistance Level
- MCB $66.59
- SIGA $7.89
- Average True Range (ATR)
- MCB 2.46
- SIGA 0.50
- MACD
- MCB 0.80
- SIGA -0.10
- Stochastic Oscillator
- MCB 85.55
- SIGA 1.46
About MCB Metropolitan Bank Holding Corp.
Metropolitan Bank Holding Corp is a bank holding company. It provides a broad range of business, commercial, and retail banking products and services to small businesses, middle-market enterprises, public entities, and individuals in the New York metropolitan area. The services provided by the company include deposits, trade finance, cash management solutions, savings, electronic banking, cards, and others. The company also provides various lending products such as acquisition loans, construction loans, and lines of credit, for retail, office, hospitality, multifamily, mixed-use, warehouse and distribution, and specialty-use properties. The bank derives its revenue in the form of interest income on loans.
About SIGA SIGA Technologies Inc.
SIGA Technologies Inc is a commercial-stage pharmaceutical company focused on the health security market. The company's main product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by the variola virus. The company derives maximum revenue from United States.